Page 44 - Big Caps News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Johnson & Johnson COVID-19 vaccine has possible link to very rare cases of unusual blood clots, says EU regulator The European Medicines Agency stated that these events should be listed as very rare side effects of the jab Johnson & Johnson’s (NYSE:JNJ) COVID-19 vaccine was found to have a possible link to very rare cases of unusual blood clots with low blood platelets, the EU regulator said. The European Medicines Agency concluded that the jab should have a warning added to the product information. It also stated that these events should be listed as very rare side effects of the vaccine.

US might reduce the nicotine content in cigarettes to non-addictive levels Menthol cigarettes might also be banned Imperial Brands PLC (LON:IMB) and British American Tobacco PLC (LON:BATS) tumbled today on a report that the US might order a reduction in the nicotine content in cigarettes. US authorities are considering the move as part of clamp-down on tobacco addiction reported the Wall Street Journal. The Food and Drug Administration has to make a decision on whether to ban menthol-flavoured cigarettes by 29 April and this has prompted it also to consider lowering nicotine level...

Clubhouse valued at US$4bn following funding round Companies Clubhouse valued at US$4bn following funding round The audio-only chat app, which allows users to create invite-only chatrooms, has seen its popularity boom in recent months following its use by several high-profile figures including Elon Musk and Mark Zuckerberg Clubhouse, an audio-only chat app, recently closed a funding round that reportedly values the company at approximately US$4bn. A report from Reuters overnight credited a source familiar with the matter for the multi-billion dollar figure, after the company announced the cl...

mVaccination has already been used in South Africa to register 279,000 inoculations of health workers Vodafone PLC (LON:VOD) announced a partnership with the African Union Development Agency (AUDA-NEPAD) to offer a digital toolbox to help with the Coronavirus (COVID-19) vaccine rollout. The mVacciNation mobile platform will manage vaccination appointments and stock availability across up to 55 countries, following a successful pilot project in South Africa. In South Africa, the National Department of Health has used mVacciNation to register health workers on its Electronic Vaccine Data System...

Liberum expects a spike in revenue after short-term headwinds this and next year GlaxoSmithKline PLC’s (LON:GSK) spinoff is expected to deliver above-sector sales growth contrary to market scepticism, analysts at Liberum said. The FTSE 100 group plans to split into two companies in 2022, consumer health and biopharma, and the outlook for the latter is regarded as the benchmark for the success of the spinoff. The City broker looked at the key product and franchise areas that will define GSK’s biopharma business over the next decade. Strong organic growth in oncology and vaccines will deliv...